1446 studies found for:    pancreatic cancer
Show Display Options
Rank Status Study
1 Recruiting Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder
Condition: Pancreatic Cancer
Interventions: Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: biopsy
2 Recruiting A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer
Conditions: Pancreatic Cancer;   Hypoxia
Intervention:
3 Recruiting Studying Biomarkers in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Genetic: protein analysis;   Other: laboratory biomarker analysis
4 Active, not recruiting Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
5 Terminated Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
6 Active, not recruiting Stool Testing for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
7 Completed Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Procedure: Endoscopic Ultrasound (EUS);   Device: EUS/4D-ELF
8 Completed Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Other: laboratory biomarker analysis
9 Recruiting Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Biological: GVAX pancreatic cancer vaccine;   Drug: cyclophosphamide
10 Active, not recruiting Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
Condition: Pancreatic Cancer
Intervention: Behavioral: Questionnaire
11 Not yet recruiting Gemcitabine and CT-011 for Resected Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Cancer of the Pancreas;   Neoplasms Pancreatic;   Pancreatic Cancer;   Pancreas Cancer
Interventions: Biological: CT-011;   Drug: Gemcitabine
12 Active, not recruiting Vaccine Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
Condition: Pancreatic Cancer
Intervention: Biological: allogenic GM-CSF plasmid-transfected pancreatic tumor cell vaccine
13 Completed Tarceva and Capecitabine for Pancreatic Cancer
Conditions: Pancreatic Cancer;   Neoplasm Metastasis
Interventions: Drug: Capecitabine;   Drug: OSI-774
14 Recruiting Pancreatic Cancer Registry for High Risk Individuals
Condition: Pancreatic Cancer
Intervention:
15 Unknown  Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
16 Completed Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis
Conditions: Pancreatic Cancer;   Precancerous Condition
Intervention:
17 Recruiting Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer
Conditions: Cancer of Pancreas;   Cancer of the Pancreas;   Neoplasms, Pancreatic;   Pancreas Cancer;   Pancreas Neoplasms
Interventions: Drug: Modified FOLFIRINOX;   Radiation: Stereotactic Body Radiotherapy (SBRT)
18 Completed Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
Conditions: Drug/Agent Toxicity by Tissue/Organ;   Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: triacetyluridine
19 Recruiting Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Mirtazapine plus gemcitabine;   Drug: Gemcitabine, placebo
20 Terminated Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Intervention: Drug: RTA 402

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years